Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Posner

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Clinical Pharmacology|January 1, 1985
The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple dosesJ Posner, A Bye, K Dean, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Analgesic, central, cardiovascular and endocrine effects of the enkephalin analogue Tyr-D.Arg-Gly-Phe(4NO2)-Pro-NH2 (443C81) in healthy volunteersJ Posner, S G Moody, A W Peck, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humansJ Soul-Lawton, E Seaber, N On, et al.
Psychopharmacology|January 15, 1999
Lack of an effect of zolmitriptan (Zomig, 311C90) on psychometric task performance: results of a placebo-controlled study in healthy volunteersA J Mercer, R J Lamb, P E Rolan, et al.
British Medical Journal|March 5, 1977
Arthritis after meningococcal meningitisH E Larson, K G Nicholson, G Loewi, et al.
Neurology|February 5, 1999
Bilateral optic neuropathy with IgGkappa multiple myeloma improved after myeloablative chemotherapyF S Lieberman, J Odel, J Hirsh, et al.
British Journal of Clinical Pharmacology|July 1, 1987
The disposition of antipyrine and its metabolites in young and elderly healthy volunteersJ Posner, M Danhof, M W Teunissen, et al.
British Journal of Clinical Pharmacology|February 1, 1995
The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agentR W Peck, R Wootton, D R Lee, et al.
Cephalalgia : an International Journal of Headache|November 1, 1996
Evaluation of non-invasive techniques to assess vasoconstriction in healthy volunteers using methoxamine as a probe drugR M Dixon, H B Meire, C Leigh, et al.
Chest|May 12, 2004
Intensive care in patients with HIV infection in the era of highly active antiretroviral therapyMangala Narasimhan, Adam J Posner, Vera A DePalo, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Pharmacology|January 1, 1985
The disposition of bupropion and its metabolites in healthy male volunteers after single and multiple dosesJ Posner, A Bye, K Dean, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Analgesic, central, cardiovascular and endocrine effects of the enkephalin analogue Tyr-D.Arg-Gly-Phe(4NO2)-Pro-NH2 (443C81) in healthy volunteersJ Posner, S G Moody, A W Peck, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humansJ Soul-Lawton, E Seaber, N On, et al.
Psychopharmacology|January 15, 1999
Lack of an effect of zolmitriptan (Zomig, 311C90) on psychometric task performance: results of a placebo-controlled study in healthy volunteersA J Mercer, R J Lamb, P E Rolan, et al.
British Medical Journal|March 5, 1977
Arthritis after meningococcal meningitisH E Larson, K G Nicholson, G Loewi, et al.
Neurology|February 5, 1999
Bilateral optic neuropathy with IgGkappa multiple myeloma improved after myeloablative chemotherapyF S Lieberman, J Odel, J Hirsh, et al.
British Journal of Clinical Pharmacology|July 1, 1987
The disposition of antipyrine and its metabolites in young and elderly healthy volunteersJ Posner, M Danhof, M W Teunissen, et al.
British Journal of Clinical Pharmacology|February 1, 1995
The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agentR W Peck, R Wootton, D R Lee, et al.
Cephalalgia : an International Journal of Headache|November 1, 1996
Evaluation of non-invasive techniques to assess vasoconstriction in healthy volunteers using methoxamine as a probe drugR M Dixon, H B Meire, C Leigh, et al.
Chest|May 12, 2004
Intensive care in patients with HIV infection in the era of highly active antiretroviral therapyMangala Narasimhan, Adam J Posner, Vera A DePalo, et al.
Pageof 11